No Data
No Data
H.C. Wainwright Maintains Vigil Neuroscience(VIGL.US) With Buy Rating, Cuts Target Price to $14
Vigil Neuroscience Is Maintained at Buy by HC Wainwright & Co.
Vigil Neuroscience Price Target Cut to $14.00/Share From $17.00 by HC Wainwright & Co.
Vigil Neuroscience Analyst Ratings
Vigil Neuroscience Price Target Lowered to $13 From $24 at Wedbush
Wedbush Cuts Price Target on Vigil Neuroscience to $13 From $24, Keeps Outperform Rating